The best studied serine proteinase inhibitors (SPIs) to date in angiogenesis, tumor invasion, and metastasis are the plasminogen activator inhibitor-1 (PAI-1), PAI-2 [8], and maspin [9]. This evidence concerns the gene SERPINE1 and neoplasm.